EX-VIVO ANTITUMOR EFFICACY OF PEGYLATED-TARGETED NANODIAMONDS FOR DOCETAXEL DELIVERY IN OVARIAN CANCER

被引:0
|
作者
Mohamed, B. [1 ]
O'Toole, S. [1 ]
Elbaruni, S. [2 ]
Norris, L. [1 ]
AbuSaadeh, F. [3 ]
Gray, S. [4 ]
O'Leary, J. [5 ]
机构
[1] Trinity Coll Dublin, Obstet & Gynaecol Histopathol, Trinity St James & Canc Inst, Dublin, Ireland
[2] Univ Tripoli, Tripoli, Libya
[3] Trinity Coll Dublin, Trinity St James & Canc Inst, Gynaecol Oncol, Dublin, Ireland
[4] Trinity Coll Dublin, Trinity St James & Canc Inst, Thorac Oncol Res Grp, Dublin, Ireland
[5] Trinity Coll Dublin, Trinity St James & Canc Inst, Histopathol, Dublin, Ireland
关键词
D O I
10.1136/ijgc-2019-ESGO.973
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP927
引用
收藏
页码:A497 / A497
页数:1
相关论文
共 50 条
  • [31] Targeted in vivo delivery of EGFR siRNA inhibits ovarian cancer growth and enhances drug sensitivity
    Minati Satpathy
    Roman Mezencev
    Lijuan Wang
    John F. McDonald
    Scientific Reports, 6
  • [32] Bile acid/fatty acid integrated nanoemulsomes for nonalcoholic fatty liver targeted lovastatin delivery: stability, in-vitro, ex-vivo, and in-vivo analyses
    Faran, Syed Ali
    Hussain, Tanveer
    Khalid, Syed Haroon
    Khan, Ikram Ullah
    Asif, Muhammad
    Ahmad, Junaid
    Rehman, Abdul
    Asghar, Sajid
    EXPERT OPINION ON DRUG DELIVERY, 2024, 21 (05) : 779 - 796
  • [33] Targeted in vivo delivery of EGFR siRNA inhibits ovarian cancer growth and enhances drug sensitivity
    Satpathy, Minati
    Mezencev, Roman
    Wang, Lijuan
    McDonald, John F.
    SCIENTIFIC REPORTS, 2016, 6
  • [34] In Vivo Delivery of Silica Nanorattle Encapsulated Docetaxel for Liver Cancer Therapy with Low Toxicity and High Efficacy
    Li, Linlin
    Tang, Fangqiong
    Liu, Huiyu
    Liu, Tianlong
    Hao, Nanjing
    Chen, Dong
    Teng, Xu
    He, Junqi
    ACS NANO, 2010, 4 (11) : 6874 - 6882
  • [35] Intraperitoneal Drug Delivery to Improve Efficacy of Targeted Therapies in Mouse Models of Epithelial Ovarian Cancer
    Pathak, Harsh B.
    JOURNAL OF WOMENS HEALTH, 2013, 22 (10) : 896 - 896
  • [36] PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response
    Riad, Aladdin
    Gitto, Sarah B.
    Lee, Hwan
    Winters, Harrison D.
    Martorano, Paul M.
    Hsieh, Chia-Ju
    Xu, Kuiying
    Omran, Dalia K.
    Powell, Daniel J., Jr.
    Mach, Robert H.
    Makvandi, Mehran
    MOLECULES, 2020, 25 (24):
  • [37] An Ex-Vivo Patient Derived Immunotherapy Platform to Investigate CAR T-Cell Efficacy against Lung Cancer
    Messinger, John
    MOLECULAR THERAPY, 2019, 27 (04) : 272 - 272
  • [38] Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer
    Yan, Jieke
    Wang, Yuzhen
    Jia, Yuxiu
    Liu, Shuangde
    Tian, Chuan
    Pan, Wengu
    Liu, Xiaoli
    Wang, Hongwei
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 88 : 374 - 383
  • [39] Self-nanoemulsifying drug delivery system (SNEDDS) of docetaxel and carvacrol synergizes the anticancer activity and enables safer toxicity profile: optimization, and in-, ex-vivo and in-vivo pharmacokinetic evaluation
    Ateeq, Mohd Aman Mohd
    Aalhate, Mayur
    Mahajan, Srushti
    Kumar, Gogikar Shiva
    Sen, Sibu
    Singh, Hoshiyar
    Gupta, Ujala
    Maji, Indrani
    Dikundwar, Amol
    Guru, Santosh Kumar
    Singh, Pankaj Kumar
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2023, 13 (10) : 2614 - 2638
  • [40] Assessment of the Efficacy of Intra-Amniotic Delivery of CSAIDs on Human Fetal Membrane Inflammation in an Ex-Vivo Two-Compartment Model.
    Stinson, Lisa F.
    Ireland, Demelza J.
    Keelan, Jeffrey A.
    REPRODUCTIVE SCIENCES, 2013, 20 (S3) : 94A - 95A